Antipsychotic-Induced Hyperprolactinaemia
2004/01/01 by Peter M Haddad, Peter Haddad, Angelika Wieck · 30 citations
Medicine · #Pituitary Gland Disorders and Treatments #Growth Hormone and Insulin-like Growth Factors #Hypothalamic control of reproductive hormones
paper · doi:10.2165/00003495-200464200-00003
Cited by
- Sexual Side Effects of Pharmacological Treatment of Psychiatric Diseases
- A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
- Prolactin, flupenthixol decanoate and first episode schizophrenia – clinical and laboratory correlates
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
- Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
- Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder. [europepmc]
- Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. [europepmc]
- The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics. [europepmc]
- Management of psychosis associated with a prolactinoma: case report and review of the literature. [europepmc]
- Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis. [europepmc]
- Is antipsychotic treatment linked to low bone mineral density and osteoporosis? A review of the evidence and the clinical implications. [europepmc]
- High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury. [europepmc]
- Prolactin serum concentrations during aripiprazole treatment in youth. [europepmc]
- Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin). [europepmc]
- Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia. [europepmc]
- Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis. [europepmc]
- Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study. [europepmc]
- Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. [europepmc]
- A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia. [europepmc]
- Clinical Course of Nonfunctional Pituitary Microadenoma in Children: A Single-Center Experience. [europepmc]
- Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines. [europepmc]
- Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. [europepmc]
- Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications. [europepmc]
- Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia: A Network Meta-Analysis of Randomized Controlled Trials. [europepmc]
- European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. [europepmc]
- The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective. [europepmc]
- Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR. [europepmc]
- Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study. [europepmc]
- Evidence-Based Recommendations for the Pharmacological Treatment of Women with Schizophrenia Spectrum Disorders. [europepmc]
- Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study. [europepmc]